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Abstract: The demand for valuable products from dinoflagellate biotechnology has increased re-
markably in recent years due to their many prospective applications. However, there remain many 
challenges that need to be addressed in order to make dinoflagellate bioactives a commercial reality. 
In this article, we describe the technical feasibility of producing and recovering amphidinol ana-
logues (AMs) excreted into a culture broth of Amphidinium carterae ACRN03, successfully cultured 
in an LED-illuminated pilot-scale (80 L) bubble column photobioreactor operated in fed-batch mode 
with a pulse feeding strategy. We report on the isolation of new structurally related AMs, amphidi-
nol 24 (1, AM24), amphidinol 25 (2, AM25) and amphidinol 26 (3, AM26), from a singular fraction 
resulting from the downstream processing. Their planar structures were elucidated by extensive 
NMR and HRMS analysis, whereas the relative configuration of the C-32→C-47 bis-tetrahydropy-
ran core was confirmed to be antipodal in accord with the recently revised configuration of AM3. 
The hemolytic activities of the new metabolites and other related derivatives were evaluated, and 
structure–activity conclusions were established. Their isolation was based on a straightforward and 
high-performance bioprocess that could be suitable for the commercial development of AMs or 
other high-value compounds from shear sensitive dinoflagellates.  




Dinoflagellates are a well-recognized source of bioactives exhibiting wide diverse 
functionality and distinctive chemical structures that show great potential for use in the 
fields of biology, biomedicine, pharmacology and toxicology [1]. However, several diffi-
culties remain in attempts to implement and commercialize these bioactive secondary me-
tabolites [2]. The limited availability of natural sources, along with their exceedingly com-
plex synthesis or the lack of knowledge of biotic and abiotic growth conditions, extreme 
shear sensitivity in photobioreactor culture, have greatly hampered their commercial de-
velopment [3–5]. 
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Despite the above difficulties, we have recently developed strategies related to the 
production of pilot-scale cultures of dinoflagellates of the genus Amphidinium [6–9]. Am-
phidinium species are known to produce super carbon chain compounds including am-
phidinols (AMs) and other related metabolites [10–14]. This growing family of opened 
long-chain polyketides, characterized by a hairpin shape constituted by a central common 
core delimited by two tetrahydropyran rings separating two moieties—one mainly poly-
hydroxilic and other polyenic—is known to elicit potent antifungal, ichthyotoxic, hemo-
lytic, cytotoxic, antiprotozoan or antidiatom activities [15]. In addition, AMs also exhibit 
strong toxicity against some problematic human pathogens, such as Candida albicans fun-
gus and bacteria belonging to Mycoplasma genus [16,17]. Antifungal and hemolytic activ-
ities are believed to correlate their structural features with their interaction with phospho-
lipid bilayers that lead to membrane permeabilization, which is believed to be independ-
ent of membrane thickness but dependent on membrane sterols [18]. 
The basis of a bioprocess strategy for achieving technically feasible recovery of AMs 
excreted into the broth by photoautotrophic culture of Amphidinium carterae using a simple 
and scalable process was assessed [6]. AMs have never been detected or recovered from 
supernatants of Amphidinium cultures; the results reported in the literature refer to AMs 
extracted from biomass pellets. Briefly, the bioprocess consists of three distinct parts: (1) 
culture of A. carterae strain ACRN03 in a pilot-scale (80 L) bubble column photobioreactor 
illuminated with multi-color LEDs operated in fed-batch mode with a pulse feeding strat-
egy to produce and recovery microalgal biomass and supernatant; (2) separation of an 
AMs-enriched extract from the supernatant by reverse phase chromatography; and (3) 
chromatographic purification, identification, dereplication and structural resolution of 
metabolites.  
Excellent yields were obtained for a new analog named amphidinol 20B [19], as well 
as the AMs luteophanol D and lingshuiol A, previously reported in other strains [20,21]. 
The concentrations of luteophanol D and lingshuiol A in the supernatant of A. carterae 
ACRN03 were much higher than those reported in cultures of other Amphidinium strains 
where both metabolites were recovered from cells and not from the processed cell-free 
culture medium, despite the recovery of AMs excreted to culture medium presenting ad-
vantages with respect to their intracellular counterparts from a downstream processing 
point of view [6]. Known and novel AMs are also expected to be present in variable quan-
tities in the cell pellets and in the remaining supernatant resulting from centrifugation 
step in the clarification system. Herein, our advances tracing the presence of this type of 
derivatives in the singular fraction resulting from the remainder supernatant in the clari-
fication system were point out. As a result, this work report on the isolation, structure 
determination and activity evaluation of three new derivatives, AMs 24–26 (1–3). 
2. Results and Discussion 
2.1. Isolation and Structural Elucidation of AMs 
When the objective of a marine dinoflagellate-based bioprocess is the identification 
and production of relatively minority specific secondary metabolites, such as AMs from 
A. carterae, the recovery of the largest amount possible of AMs becomes a priority. In the 
process of biomass harvesting from the Amphidinium photobioreactor culture, three frac-
tions were clearly identified where the presence of AMs was likely. The first corresponded 
to the wet cell biomass pellet, a second one was related to the clarified cell-free culture 
medium, and a third included the supernatant (1 L) that remained in the clarification 
equipment. The presence of AMs in the second one was analyzed in a previous study [6]. 
Thus, in this work, the third fraction was investigated. The methanolic extract (10.9 g) 
from the reddish lyophilized supernatant was subjected to a series of chromatographic 
steps to provide two known AM derivatives (luteophanol D and AM20B) and three new 
AM derivatives, AM24 (1) 6.8 mg; AM25 (2) 1.2 mg, and AM26 (3) 1.8 mg (Figure 1). 




Figure 1. Structures of new AMs identified in Amphidinium carterae cultures. 
The molecular formula C66H116O27 for AM24 (1) was determined by HRESIMS analy-
sis (m/z 1363.7606 [M + Na]+; calcd. 1363.7602), accounting for a highly oxygenated mole-
cule with nine degrees of unsaturation. The NMR data (Table 1) in CD3OD revealed a total 
of 66 carbons assigned to eleven sp2 methines, one sp2 methylene, twenty-seven oxygen-
ated sp3 methines, two oxygenated sp3 methylenes, one sp3 methine, twenty sp3 methyl-
enes, two methyls and two quaternary sp2 carbons. The 1H NMR spectrum showed con-
siderable signal overlap, especially in the regions δH 1.30→2.40 and 3.40→4.15; hence, a 
meticulous analysis of COSY, TOCSY, HSQC, HSQC-TOCSY, and H2BC spectra, allowed 
the identification of three independent 1H—1H spin systems A–C (Figure 2). Thus, the 
structural resolution of Fragment A was started at the methylene carbon C-1 (δH 3.43, 3.48; 
δC 67.0) and the linear connections determined allowed us to establish the sequence up to 
the methylene carbon C-27 (δH 2.12, 2.21; δC 36.8), including the pendant methyl group C-
64 (δH 0.98; δC 6.6) branched to C-21 (δH 2.30; δC 35.0). Analogously, the linear connections 
of sp2 methine carbon C-29 (δH 5.48; δC 125.9) to the methylene carbon C-39 (δH 2.10, 2.42; 
δC 27.8) unequivocally constructed the Fragment B. In addition, the rest of the observed 
linear connectivities revealed the Fragment C between the oxymethine C-41 (δH 4.18; δC 
76.3) and the oxymethylene C-63 (δH 3.43, 3.48; δC 67.8) carbons. The partial structures A, 
B and C were linked together through quaternary carbons on the basis of key HMBC and 
H2BC correlations. Thus, the connection between the substructures A and B was secured 
by the correlations of protons H2-27, H-29, and those of the methyl group at C-65 (δH 1.75; 
δC 17.1) with C-28 (δC 139.0). Furthermore, cross-peaks of H2-39, H-41 and the sp2 meth-
ylene H2-66 (δH 4.99, 5.08; δC 112.8) with the sp2 quaternary carbon C-40 (δC 151.4) allowed 
us to join the two Fragments B and C (Figure 2). The planar structure was completed with 
the confirmation of the presence of two tetrahydropyran rings on the basis of two long-
range correlations between H-36/C-32 and H-47/C-43. Further confirmation of the struc-
ture of 1 was obtained from mass spectral fragmentation (see Supporting Information, 
Figure S17). 
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Table 1. NMR data for AMs 24–26 (compounds 1–3) (600 MHz; 300 °K, CD3OD). 
 AM24 (1) AM25 (2) AM26 (3) 
Carbon nº δC, Type δH δC, Type δH δC, Type δH 
1 67.0, CH2 3.43; 3.48 67.1, CH2 3.43; 3.47 67.1, CH2 3.43; 3.48 
2 73.0, CH 3.58 73.1, CH 3.59 73.1, CH 3.59 
3 34.2, CH2 1.38; 1.54 34.3, CH2 1.37; 1.54 34.3, CH2 1.38; 1.54 
4 22.6, CH2 1.38; 1.62 22.6, CH2 1.38; 1.61 22.6, CH2 1.38; 1.61 
5 38.2, CH2 1.40; 1.50 38.2, CH2 1.40; 1.50 38.1, CH2 1.40; 1.50 
6 72.0, CH 3.54 72.1, CH 3.54 72.0, CH 3.56 
7 38.2, CH2 1.40; 1.50 38.2, CH2 1.40; 1.50 38.1, CH2 1.40; 1.50 
8 22.6, CH2 1.38; 1.62 22.6, CH2 1.38; 1.61 22.6, CH2 1.38; 1.62 
9 37.6, CH2 1.40; 1.52 37.6, CH2 1.39; 1.52 37.7, CH2 1.40; 1.52 
10 71.9, CH 3.58 72.2, CH 3.58 72.4, CH 3.59 
11 41.2, CH2 2.20 (2H) 41.4, CH2 2.20 (2H) 41.2, CH2 2.19 (2H) 
12 128.6, CH 5.69 128.6, CH 5.68 128.5, CH 5.70 
13 136.0, CH 5.53 135.9, CH 5.53 135.9, CH 5.55 
14 73.2, CH 4.05 73.3, CH 4.05 73.2, CH 4.05 
15 41.7, CH2 2.25 (2H) 41.8, CH2 2.24 (2H) 41.7, CH2 2.24 (2H) 
16 129.7, CH 5.54 129.6, CH 5.53 129.6, CH 5.55 
17 137.3, CH 5.60 130.1, CH 5.60 130.1, CH 5.60 
18 37.7, CH2 2.08; 2.48 37.7, CH2 2.08; 2.48 37.7, CH2 2.08; 2.48 
19 72.2, CH 3.52 72.2, CH 3.52 72.1, CH 3.52 
20 78.9, CH 3.52 78.7, CH 3.52 78.7, CH 3.52 
21 35.0, CH 2.30 35.0, CH 2.30 34.9, CH 2.30 
22 79.9, CH 3.53 79.6, CH 3.53 79.7, CH 3.53 
23 71.7, CH 3.71 71.2, CH 3.71 71.7, CH 3.72 
24 40.7, CH2 1.54; 1.91 40.9, CH2 1.53; 1.91 40.8, CH2 1.54; 1.90 
25 71.1, CH 3.86 71.1, CH 3.86 70.1, CH 3.87 
26 36.2, CH2 1.59; 1.68 37.4, CH2 1.59; 1.68 36.2, CH2 1.59; 1.68 
27 36.8, CH2 2.12; 2.21 36.5, CH2 2.12; 2.21 36.4, CH2 1.54; 1.90 
28 139.0, C   139.0, C   139.1, C   
29 125.9, CH 5.48 125.9, CH 5.48 125.8, CH 5.48 
30 67.6, CH 4.55 67.6, CH 4.55 67.6, CH 4.56 
31 72.0, CH 3.69 72.0, CH 3.69 72.0, CH 3.68 
32 78.8, CH 3.96 78.9, CH 3.97 78.8, CH 3.96 
33 67.1, CH 3.97 68.4, CH 4.04 68.4, CH 4.05 
34 68.4, CH 4.04 68.4, CH 3.97 67.1, CH 3.98 
35 30.0, CH2 1.79 (2H) 30.1, CH2 1.79 (2H) 30.1, CH2 1.79 (2H) 
36 75.3, CH 3.49 75.3, CH 3.49 75.3, CH 3.49 
37 74.2, CH 3.60 74.1, CH 3.60 74.1, CH 3.61 
38 32.1, CH2 1.57; 1.97 32.3 CH2 1.57; 1.97 32.2 CH2 1.56; 1.97 
39 27.8, CH2 2.10; 2.42 27.9, CH2 2.10; 2.42 28.0, CH2 2.10; 2.41 
40 151.4, C   151.1, C   151.2, C   
41 76.3, CH 4.18 76.2, CH 4.18 76.1, CH 4.19 
42 74.1, CH 3.35 75.0, CH 3.34 75.0, CH 3.35 
43 70.0, CH 4.05 70.1, CH 4.04 70.2, CH 4.04 
44 31.1 CH2 1.56; 2.09 31.3, CH2 1.56; 2.09 31.2, CH2 1.56; 2.09 
45 66.8, CH 4.05 67.1, CH 4.05 67.2, CH 4.05 
46 68.4, CH 4.05 68.4, CH 4.04 68.4, CH 4.05 
47 80.2, CH 3.74 80.3, CH 3.75 80.1, CH 3.75 
48 71.6, CH 3.97 71.7, CH 3.96 71.6, CH 3.97 
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49 73.8, CH 4.37 73.9, CH 4.36 73.7, CH 4.37 
50 128.6, CH 5.64 128.6, CH 5.63 128.5, CH 5.66 
51 134.9, CH 5.80 135.0, CH 5.80 134.7, CH 5.83 
52 29.3, CH2 2.16 (2H) 29.4, CH2 2.15 (2H) 29.4, CH2 2.18 (2H) 
53 37.6, CH2 1.60; 1.64 37.6, CH2 1.62 (2H) 38.8 *, CH2 2.16 * (2H) 
54 72.2, CH 4.12 72.4, CH 4.11 182.8 *, C   
55 137.0, CH 5.69 133.8, CH 5.67 6.7, CH3 0.97 
56 130.7, CH 6.23 130.7, CH 6.23 17.1, CH3 1.75 
57 130.7, CH 6.23 130.7, CH 6.23 
112.6, CH2 
4.99; 5.09 
58 137.0, CH 5.69 133.8, CH 5.67  
59 72.8, CH 4.10 72.4, CH 4.11     
60 34.2, CH2 1.59; 1.71 33.7, CH2 1.71; 1.73     
61 34.2, CH2 1.38; 1.54 34.2, CH2 1.71; 1.87     
62 73.0, CH 3.58 77.3, CH 4.50     
63 67.8, CH2 3.43; 3.48 69.1, CH2 4.10; 4.26     
64 6.6, CH3 0.98 6.7, CH3 0.98     
65 17.1, CH3 1.75 17.1, CH3 1.75     
66 112.8, CH2 4.99; 5.08 112.7, CH2 4.99; 5.08     
* Determined as AM27 (5). 
 
Figure 2. Partial structures obtained from COSY, TOCSY, HSQC, HSQC-TOCSY and H2BC analysis 
of AM24 (1) (Blue lines). Key fragmentation pattern for AMs 24–26 (1–3) observed in MS/MS spectra. 
The relative configurations of the tetrahydropyran rings were deduced by distinctive 
NOE effects (Figure 3). NOE interactions between H-31/H-36, H-31/H-34 and H-34/H-36 
suggested a chair conformation for the ring from C-32 to C-36 with H-34 and H-36 in 1,3-
diaxial orientation. Similarly, the chair conformation of the ring from C-43 to C-47 with 
the axial orientations of H-43 and H-45 was supported by the NOE correlations between 
H-43/H-45, H-43/H-48 and H-45/H-48. 
A B 
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Figure 3. Relative configurations of the tetrahydropyran rings (C-32/C-36 (A) and C-43/C-47 (B)) 
and distinctive ROE interactions of compound 1. 
Interestingly, the central section C-30→C-49, including the two tetrahydropyran 
rings, was identical to the central core of AM3. Recently, Wakamiya et al. [22] revised the 
absolute configuration of AM3 by comparing the NMR data between the natural product 
and the synthetic model compounds 4a and 4b. To establish the relative configuration of 
the common substructure in compound 1, a comparative analysis of the NMR chemical 
shifts in 2:1 CD3OD/C5D5N (Table S2) with those of 4a and 4b was carried out and the 
results are shown in Figure 4. Larger deviations of the C-30→C-49 portion of 1 with 4a 
were observed in both 1H and 13C chemical shifts, whereas the analysis with 4b revealed 
that it had a configuration similar to that of 1. Therefore, the configurations at C-30→C-34 
and C-36 in compound 1 are in plausible concordance with those in the revised AM3, and 
we propose 30S, 31R, 32S, 33S, 34S, and 36S to have two antipodal tetrahydropyran 





Figure 4. Comparative analysis of NMR data in 2:1 CD3OD/C5D5N for fragment C-30→C-49 be-
tween the chemical shifts of AM24 (1) and those from compounds 4a and 4b synthesized by Waka-













AM-24 vs. 4a 
AM-24 vs. 4b 
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HRESIMS analysis of AM25 (2) revealed a molecular formula of C66H115NaO33S2 based 
on the m/z 1521.6678 ([M − H]−, calcd. 1521.6581, C66H115NaO33S2) of the observed peak, in 
negative mode. The structure of this metabolite was determined by comparison of its spec-
troscopic data with those of AM24 (1); in fact, the NMR spectra indicate that both com-
pounds are closely related (Table 1). AM25 (2) differs from 1 mainly in the downfield shifts 
of the oxygenated methine and methylene assigned to C-62 and C-63 (δH 4.50; δC 77.3 and 
δH 4.10, 4.26; δC 69.1 in 2 vs. δH 3.58; δC 73.0 and δH 3.43, 3.48; δC 67.8 in 1), which are 
consistent as the site of attachment of two sulfate groups at the 1,2-polyol terminus of 1 
(Figure 1). The fragmentation pattern of 2 corresponds to the proposed arrangement of 
the sulfate ester linked at C-62 and C-63 groups, indeed all the fragment ions could be 
assigned (Figure S24). 
Compound 3, AM26, was obtained as an amorphous white solid. The molecular for-
mula was established by HRESIMS as C57H100O24 (m/z 1191.6482 [M + Na]+; calcd. 
1191.6502, C57H100O24Na). Comparison of the 1H and 13C NMR data of 3 with those of 1 
(Table 1) revealed very close similarity in the structures of both compounds sharing the 
same C-1→C-52 system. The structure of this metabolite was determined by comparison 
of its spectroscopic data with those of AM24 (1) (Table 1). The presence of the characteris-
tic ion peak (Figures 2, 5 and S33) suggests a similar C-1→C-41 moiety with respect to 
AMs 24 and 25. The structural difference between 1 and 3 turned out to reside in the ter-
minal C-51→C-63, which was truncated by C-54/C-55. Thus, the main difference in their 
NMR spectra was the leaking of signals corresponding to fragment C-51→C-63. A 1H-1H 
spin system was built for the final fragment of this molecule, but as its carboxylic deriva-
tive, since it underwent oxidation during the NMR experiments, a fact that was confirmed 
by MS (Figures S33 and S34) giving rise to AM27 (5) (Table S1). Thus, the corresponding 
Fragment C was constructed from the proton signal H-41 (δH 4.19; δC 76.1), which is cou-
pled as being similar to 1 and 2, and ends in the methylene group H2-53 (δH 2.16 (2H); δC 
38.8). Long-range 1H-13C connectivities extracted from the HMBC experiment allowed us 
to connect this substructure within the rest of the molecule and with the carboxylic carbon 
at 182.8 (C-54). The close similarity in the 1H and 13C NMR shifts of the common part C-
1→C-49 of compounds 1, 2 and 3 (Table 1) and NOE correlations analysis showed that the 
relative stereochemistry for the central core C-30→C-49 should be the same as the one 
revised for AM3 [22].  




Figure 5. Key mass fragments of AM24 (1) (A), AM25 (2) (B), and AM26 (3) (C). 
As part of our ongoing study into the technical feasibility of producing and recover-
ing AMs from pilot-scale photobioreactor cultures of Amphidinium carterae, three new am-
phidinols, AMs 24–26, together with luteophanol D and AM20B were isolated from the 
remaining supernatant in the continuous clarifying centrifugal separator system. Com-
pared to the 78 L supernatant [6], the yields of the luteophanol D and AM20B were higher, 
while lingshuiol A was undetected. Interestingly, these findings may be the result of at 
least two scenarios. The first of them would correspond to a possible breakage of cells by 
excess centrifugation treatment and the release of intracellular AMs to the supernatant. 
Although it cannot be dismissed, it is unlikely that lysis was as significant, as centrifuga-
tion conditions to prevent it were selected on the basis of a previous study [23]. 
Discarding cell breakage as the main cause responsible, the second scenario, more 
likely from our point of view, would point to centrifugation treatment intensity as a stress 
factor responsible for stimulating cell secretion intensity and altering the profile of se-
creted AMs. The rationale behind this is related to the well-known flow pattern associated 
with a tubular centrifuge like that used in our work [24]. Briefly, the feed (i.e., culture) 
flow inside the centrifuge actually takes place in an inner, much smaller annulus just be-
low the outer stagnant liquid annulus. The depth of this moving, or boundary, layer is 
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thin, yet relatively constant in thickness along the axial direction of the centrifuge. The 
moving layer is in contact with the more stagnant quiescent thicker layer which occupies 
almost the entire annular pool. This rotating stagnant supernatant pool has little interac-
tion with the moving layer. In turn, this layer accumulates the cells that settle on the bowl 
surface forming the pellet. Given the low g-force used in our study (1000 g), the con-
sistency of the pellet was similar to that of a mud. The time that the cells remain in this 
pellet is variable: from 0 h for the last sedimented cells, to approximately 7 h for the first 
ones (feed flow = 12–13 L/h). It is evident that the environment of these cells maintained 
for hours was really stressful: (i) pelleted cells are without access to nutrients and CO2 and 
(ii) continuously subjected to hydrodynamic stress. Under these conditions, it is quite 
risky to ensure that the stagnant supernatant pool harvested had an AMs profile similar 
to that detected in the 78 L supernatant. These are conditions that on the scale of hours 
can stimulate the excretion of some AMs to the detriment of others (no excretion during 
the culture) to the liquid surrounding the cells pellet in the mud, even leading to the oxi-
dation or metabolization of the AMs initially present in the stagnant liquid pool. It is well 
documented that excess shear forces can boost the production of polyketides by dinoflag-
ellates [25,26]. These newly synthesized AMs within the centrifugal separator might be 
mixed with the remainder of the supernatant in the bowl as a consequence of the turbu-
lence generated in the liquid during the deceleration of the centrifuge bowl until it stops. 
Although the excretion of polyketides by dinoflagellates into the culture medium has 
scarcely been studied, it is not a new matter. Intriguingly, published information is di-
verse. In terms of intracellular versus extracellular compounds, and depending on the 
growth phase, some of the studies reported almost perfectly mirror each other. In contrast, 
other polyketides are excreted in amounts that can be up to nine times higher than those 
recovered from the cell pellet [27,28]. In a few cases, specific polyketides were not detected 
in the cells (probably due to its low concentration), but in the supernatant [29,30]. In the 
case of AMs, data reported in the literature refer to compounds extracted from biomass 
pellets. For example, the concentration of cellular luteophanol D in a 750 L culture of Am-
phidinium sp. is as low as 1.2 μg L−1 [20]; 400-fold times lower than that obtained in our 
previously analyzed supernatant of 78 L [6]. On the other hand, a recent study revealed 
that the AM profile and cell quotas of eight Amphidinium strains were extraordinarily di-
verse [14]. In that study, lingshuiol A (3 fg cell−1) and luteophanol D (<1 fg cell−1) were 
detected in cells of the strain ACRN03 (the same strain as in the study presented here), 
but at a trace level (near the limit of detection). Meanwhile, other strains could either ac-
cumulate cell quotas as high as up to lingshuiol A 1876 fg cell−1 and luteophanol D 131 fg 
cell−1, or did not present any trace of AMs.  
2.2. Hemolytic Activity 
The membrane disrupting and permeabilizing capabilities of AMs have been system-
atically studied, since these metabolites elicit potent hemolytic and antifungal activities 
[2]. AMs are singular marine natural products that are active on cell membranes via pore 
formation in a sterol-dependent manner [18,31,32]. These pores do not obey a cylindrical 
geometry or symmetry, but they possess a polymorphic nature, which depends on the 
different AM concentration ranges. Thereby, pore diameters can reach ~10 nm at the sur-
face, measured by atomic force microscopy (AFM) [33], and an estimated inner diameter 
between 2.0–2.9 nm that can reach 4 nm, according to results obtained from osmotic pro-
tection experiments on erythrocytes [34] and conductance tests [33].  
Although the mode of action of AMs has not been fully elucidated, it is currently 
accepted that AMs act on the 3-OH beta groups of sterols exposed to extracellular media, 
leading to a stable complexation as a key step for subsequent insertion into membranes 
[35]. Evidence on specific molecular recognition has shown that the interaction occurs in 
the core region, delimited by the tetrahydropyran rings, and involving some atoms be-
yond [36]. This hyper-conserved structural motif in AMs turns and folds the molecule 
itself, which is stabilized by intramolecular hydrogen bonds, thus conferring the molecule 
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the characteristic hairpin conformation implied in the selective sterol recognition [37–40]. 
There are two main hypothetical models for the formation of AMs channels in the mem-
brane: the barrel stave model, in which AMs are stabilized when embedded in the mem-
branes by self-assembly, forming a pore, and the toroidal model, in which the polyene 
moiety of AMs interacts with the lipid bulk of membranes, whereas the polar fragments 
(polyhydroxylated section) do so with water and phosphocholine on the outer side. Fur-
thermore, Iwamoto et al. [33] proposed that both molecular models coexist at all concen-
tration ranges, suggesting morphological transitions between smaller barrel-stave type 
channels at low AM concentrations, and jumbo pores with a toroidal nature at higher con-
centrations. These characteristic and unique features make AMs attractive candidates for 
antimycotic drug development and as hemolytic agents, with AM3 being the most active 
analogue, often used as a model in both cases [35]. 
Thus, AMs 24–26 (1–3) and the previously reported luteophanol D and AM20B were 
evaluated against bovine and Sparus aurata erythrocytes using the methodology described 
by Eschbach et al. [41]. No hemolytic effects were observed in erythrocytes from defib-
rinated sheep blood and gilthead sea bream Sparus aurata at concentrations below 10 μM 
and 128 μM (13.4 and 171.5 μg mL−1 for AM24), respectively. This lack of activity proves 
that other structural features participate in poration besides sterol complexation. In this 
sense, two main aspects were considered: cellular structures (membrane constituents) and 
variable molecular motifs in AMs. It has been shown that AM activity is enhanced by the 
presence of transmembrane glycophorin A (GpA), protein especially abundant in eryth-
rocytes and the target for the interaction of some peptidic toxins such as alpha-hemolysin 
[42]. Several studies on these proteins have proved the affinity of AMs to the GpA trans-
membrane domain, being able to dissociate protein oligomers linked at that point. Other 
participative structures on cell membranes like glycolipids have been proposed for con-
sideration [13,35]. 
The lack of hemolytic activity of compounds 1–3 can be explained based on their 
structural motifs in comparison with the structure–activity relationship studies of several 
known analogues. It was observed that the hemolytic effects were not influenced, up to a 
point, by differences in the length and the structure of the polyhydroxyl initial chain 
among these families of compounds [43,44]. In contrast, they are dramatically affected by 
the hydrophobicity of the polyene chain of some AMs. A direct interaction between poly-
olefins and lipid bulk in membranes has been pointed out as being a crucial step for pore 
formation [34,36,45]. An analysis of the CLog P of the terminal carbon chains of the new 
compounds versus AM3 reveals important differences in lipophilicity (Table 2), since lu-
teophanol D, AMs 20B, 24 (1) and 25 (2) contain hydroxyl groups with a diene portion 
instead of a conjugated triene. The importance of the C-polyene chain for biological effi-
cacy has been illustrated for the case of luteophanol A, which shares the same polyhy-
droxy chain as luteophanol D (CLogP 0.44), containing two hydroxyl groups, in contrast 
to AM3 (CLogP 4.32), and showing no hemolytic activity [46]. The presence of highly hy-
droxylated branches in the new compounds must drastically reduce the interaction with 
GpA [42] and their capacity for membrane permeabilization. As a consequence, no hemo-
lytic effects were observed [46]. The hemolytic activity depletion may be due to poration 
inability, since the polyene puncture is involved in earlier steps [34,40]. Furthermore, 
AM24 (1) shows the additional negative effect of the replacement of the terminal vinyl 
fragment by hydroxyl groups [43]. In the case of AM25 (2), the substitution is for a disul-
fate ester group, which was observed to always result in reduced activity [47]. Finally, the 
absence of hemolytic activity for AM26 (3) (or AM27 (5)) as a direct consequence of the 
truncated polyene chain is also in complete agreement with its increasing polarity (CLopP 
−1.20) (Table 2). In conclusion, the lack of activity of the molecules reported in this work 
can be correlated with their highly hydroxylated structures, additional presence of sul-
fated groups or the shortening of the crucial amphipathic polyenic terminus.  
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Table 2. CLog P values for the polyene side chain of AMs identified in A. carterae ACRN03 vs. 
AM3. 
Compound CLog P Molecular Fragment 
AM3 4.32 
 












3. Materials and Methods 
3.1. General Experimental Procedures 
Optical rotations were measured on a Perkin–Elmer 241 polarimeter (Waltham, MA, 
USA) equipped with a sodium lamp. IR spectra were recorded on a Bruker IFS55 spectro-
photometer (Ettlingen, Germany) using methanolic solutions over NaCl disk. UV spectra 
were acquired on a Jasco V-560 spectrophotometer (Easton, MD, USA). NMR spectra were 
recorded on a Bruker AVANCE 600 MHz instrument (Karlsruhe, Germany) equipped 
with a 5-mm TCI (Triple Resonance CryoProbe) inverse detection cryo-probe. 1H and 13C 
NMR chemical shifts were reported in ppm and referenced to internal residual solvent 
CD3OD at 300 K (δH 3.31 ppm; δC 49.0 ppm). NMR experiments were performed using 
standard pulse sequences. NMR data were processed using Topspin or MestReNova soft-
ware (v.10., Santiago de Compostela, Spain). Mass spectra were recorded on a LCT Prem-
ier XE Micromass spectrometer (Waters, Milford, CT, USA) and on a Waters Acquity H 
Class UHPLC with Q-Tof LCT Premier XE System (Waters, Milford, CT, USA). HPLC 
(High-performance liquid chromatography) separations were carried out with a Water 
system (Waters, Milford, CT, USA) equipped with a Binary HPLC Pump 1525 and Photo-
diode Array Detector 2996. All of the solvents used were HPLC-grade. Chromatography 
was monitored by TLC, performed on Silica gel Merck 60 F254. TLC (thin layer chroma-
tography) (Merck, Darmstadt, Germany) plates were visualized using UV light (365 nm) 
and 10 wt% phosphomolybdic acid solution in methanol. 
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3.2. Biological Material 
Amphidinium carterae, strain ACRN03, was the marine dinoflagellate microalga used. 
Cells were obtained from the Culture Collection of Harmful Microalgae at the IEO (Vigo, 
Spain). The inoculum for the photobioreactor was grown indoors under artificial light (60 
μmol photons m−2 s−1 light flux at the vessel’s surface) in flasks at 21 ± 1 °C under a 12:12 
h light–dark cycle. Illumination was supplied by four 58 W fluorescent lamps. The culture 
medium consisted of filter-sterilized (0.22 μm Millipore filter; Millipore Corporation, 
Billerica, MA, USA) modified K medium [48] prepared in Mediterranean seawater. The 
modified K medium composition was: NaNO3, 882 μM; NH4Cl, 50 μM; NaH2PO4, 10 μM; 
TRIS, 1 mM; Na2EDTA·2H2O, 90 μM; Fe-Na-EDTA, 14.6 μM; MnCl2·4H2O, 0.9 μM; 
ZnSO4·7H2O, 0.08 μM; CoSO4·7H2O, 0.05 μM; Na2MoO4·2H2O, 0.03 μM; H2SeO3, 0.01 μM; 
thiamine, 0.7 μM; biotin, 2.1 nM; B12, 0.37 nM. 
3.3. Cultivation in the LED-Based Bubble Column PBR 
Amphidinium carterae ACRN03 was photoautotrophically cultured in an LED-illumi-
nated bubble column PBR (Figure 6) as previously described [6]. Briefly, the air flow rate 
remained below 0.06 vvm to ensure freedom from damaging levels of hydrodynamic 
stress. Illumination was provided by multicolor LED strips (red, green, blue and warm 
white, collectively referred to as RGBG; Edison Opto Co., Taiwan) attached horizontally 
to the insides of two semicircular reflective plastic (PVC) covers that surrounded the PBR. 
A sinusoidal diel variation pattern was imposed in which the maximum irradiance occur-
ring at midday was fixed at 1500 μmol photons m−2 s−1. Additional details of the culture 
system have been reported previously [49]. The culture temperature was controlled at 21 
± 1 °C and the pH was controlled at pH 8.5 by automatically injecting carbon dioxide, as 
needed. The modified K medium was prepared using filter-sterilized Mediterranean sea-
water. The medium (65 L) was inoculated with 15 L of an inoculum containing microalgal 
cells in the late exponential growth phase. The cell concentration in the freshly inoculated 
photobioreactor was around 30,000 cells mL−1. The PBR was operated in fed-batch mode 
with a pulse feeding strategy. In this procedure, repeated medium replacement was per-
formed every time a stationary growth phase appeared. This replacement consisted of 
removing 2 L of the broth and replacing it with an equal volume containing a nutrient 
stock equivalent to 80 L of the modified K medium. Once pulses of nutrient stock did not 
increase the cell concentration, a stationary growth phase was maintained for 10 days by 
adding small amounts of nutrient stock (equivalent to 8 L of modified K medium) to com-
pensate the nutritional requirements of basal metabolism.  
  
Figure 6. Pilot-scale bubble column photobioreactor system used in obtaining the data presented 
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(B). Optical microscope images of living cells of Amphidinium carterae ACRN03 taken at 20X (scale 
bar = 200 μm) (C) and 40X (scale bar = 100 μm) (D) magnification. 
3.4. Extraction and Chromatographic Separation 
At the end of the culture period, continuous centrifugation (RINA, model 
100M/200M, Spain) operated at 1000× g and fed with a broth flow rate as 13 L h−1 was 
applied to separate the microalga from the culture medium. The culture of nearly 80 L 
provided slightly more than 1 L of microalgal mud and about 78 L of supernatant. Then, 
in a second centrifugation step (benchtop centrifuge, model SIGMA 4-15C, 2000× g), the 
wet biomass pellet was separated from the microalgal mud and a reddish supernatant 
recovered (1 L). This supernatant was lyophilized and extracted with methanol yielding, 
after filtration and solvent removal, a viscous dark green residue of 10.9 g (Figure 7). This 
work was focused on the AMs present in the supernatant siphoned off.  
 
Figure 7. Production of new AM analogues by the marine microalga Amphidinium carterae grown in a pilot-scale LED-
illuminated photobioreactor. 
The extract (AC03 Fraction S) was subjected to a gel filtration using Sephadex LH-20 
(65 × 275 mm) eluted with methanol obtaining six fractions. The first fraction (269 mg) was 
initially separated by a medium pressure reverse phase LC Lobar LiChroprep RP-18 col-
umn (25 × 310 mm) using a stepped gradient (52 min) from MeOH:CH3CN:H2O (1:2:7) to 
100% CH3CN at 3 mL min−1 to yield nine new fractions S1A-S1I (see Supplementary Ma-
terial, Scheme S2). The fraction S1B (104.2 mg) was rechromatographed in the above col-
umn using MeOH:H2O (3:17 to 1:0, 140 min) at 2 mL min−1. Fraction S1B–D (1.3 mg) was 
further purified by HPLC on a Water μ-Bondapack C18 column (19 × 150 mm) eluted with 
MeOH:H2O (3:17 to 1:0, 90 min), 1 mL min−1 to afford pure AM25 (2, 1.2 mg, tR = 56.5 min), 
whereas the fraction S1B–F (41.1 mg) was purified first by a medium pressure reverse 
phase (Lobar LiChroprep RP-18 column, 25 × 310 mm) with a gradient mobile phase (1:2:7 
to 1:0:0 MeOH:CH3CN:H2O over 155 min, 2 mL min−1) to afford crude fractions of AM26 
and AM24. Each fraction was subsequent final purified using HPLC (μ-Bondapack C18 
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mL min−1) and isocratic (MeOH:CH3CN:H2O, 1:2:7, 1 mL min−1) mobile phase, respec-
tively, to yield AM26 (3, 1.8 mg, tR = 34.0 min) and AM24 (1, 6.8 mg, tR = 18.0 min). Known 
compounds luteophanol D (4.6 mg) and AM20B (1.3 mg) were also isolated from the frac-
tions S1F and S1B–F, respectively (Figure 1, Scheme S2). Lingshuiol A was not detected in 
this study. 
Amphidinol 24 (1): Yellow oil; [α]25D +13 (c 0.09, MeOH); UV (MeOH) λmax 230 nm (ε 
27123); IR νmax 3264, 2931, 2366, 2345, 2034, 2011, 1978, 1608 and 1020 cm−1; 1H and 13C 
NMR data (CD3OD) see Table 1; HRESIMS m/z 1363.7606 [M + Na]+ (calcd. 1363.7602 for 
C66H116O27Na).  
Amphidinol 25 (2): Yellow oil; [α]25D +1 (c 0.13, MeOH); IR νmax 3266, 2940, 2867, 2364, 
2167, 2034, 1976, 1614 and 1022 cm−1; 1H and 13C NMR data (CD3OD) see Table 1; HRESIMS 
m/z 1521.6678 [M − H]− (calcd. 1521.6581 for C66H114O33NaS2). 
Amphidinol 26 (3): Colorless amorphous solid; [α]25D −30 (c 0.13, MeOH); IR νmax 3262, 
2832, 2366, 2167, 2034, 1976, 1613 and 1022 cm−1; 1H and 13C NMR data (CD3OD) see Table 
1; HRESIMS m/z 1191.6482 [M + Na]+ (calcd. 1191.6502 for C57H100O24Na). 
The known compounds luteophanol D and amphidinol 20B were identified by de-
tailed analysis of the NMR and MS spectrometric data (Figures S36–S39) and comparison 
with those reported in the literature [6,20]. 
3.5. Hemolytic Assays 
Erythrocyte lysis assay was performed as described elsewhere [41]. Erythrocytes 
from defibrinated sheep blood and from gilt-head (sea) bream (Sparus aurata) grown in a 
fish farm (blood was collected by caudal vein puncture). Serial methanolic dilutions of 
AMs 24–26 (1–3), luteophanol D and AM20B were placed in a microwell and air dried. 
The concentrations of AMs in microwells ranged from 0 to 5.5 × 104 ng mL−1. A erythrocyte 
concentration of 45 × 106 cells per well was used. Negative controls consisted of erythro-
cytes incubated in Mediterranean seawater. Positive control, i.e., 100% hemolysis, was ob-
tained using distilled water. The dose–response curves (percentage of hemolysis (PH) vs. 
log of number of A. carterae cells per well (x)) were interpreted in terms of the Hill Equa-
tion (1): 𝑃𝐻 =  𝑃𝐻 + 𝑃𝐻 − 𝑃𝐻1 + 𝑥 𝐸𝐶  (1) 
where PH is the percentage of hemolysis; x is the concentration of AM per well; PHmax 
represents the maximum percentage of hemolysis equal to 100%; EC50 is the concentration 
of AM per well giving 50% hemolysis and η is the Hill slope. Saponin (Sigma Aldrich, 
47036, CAS nº 8047-15-2, Saint Louis, MO, USA), was used as a positive control obtaining 
an EC50 value of 10.7 × 106 ± 1.06 × 106 pg per well through Hill equation. An equivalent 
saponin potency (pg per AM pg) was calculated by dividing the EC50 for saponin by the 
EC50 for AM. 
4. Conclusions 
Three new related amphidinol analogues, named amphidinol 24, amphidinol 25 and 
amphidinol 26, were obtained from the marine dinoflagellate Amphidinium carterae, suc-
cessfully cultured in a pilot-scale bubble column photobioreactor illuminated with multi-
color light-emitting diodes (LEDs) operated in fed-batch mode with a pulse feeding strat-
egy. The structures were established by extensive spectroscopic methods, while the rela-
tive configurations of the C16 common central core (C-32→C-47) were determined by 
comparison of the NMR data of AM24 with those of two synthetic intermediates of AM3 
[22]. The results confirm that both tetrahydropyran counterparts exist as antipodal moie-
ties on a single carbon chain, in accordance with that unique structural aspect of the re-
cently revised configuration of AM3.  
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A structure–activity relationship study of the new metabolites and other related de-
rivatives against hemolytic activity was carried out, and it was observed that they are 
dramatically affected by the hydrophobicity (rationalized in the form of log P) of the pol-
yene chain. The lack of activity of the molecules concerned can be correlated with their 
highly hydroxylated structures, additional presence of sulfated groups, or the shortening 
of the crucial amphipathic polyenic terminus.  
This work reveals, in terms of acclimation, growth rates, biomass productivity, 
downstream processing and excellent recovery yields of excreted AM analogs, a useful 
bioprocess strategy that may be adaptable to a suitable production of other super carbon 
chain compounds or biotoxins from marine dinoflagellates. 
Supplementary Materials: The following are available online at www.mdpi.com/arti-
cle/10.3390/md19080432/s1, Scheme S1: Production of new amphidinol analogues by the marine mi-
croalga Amphidinium carterae grown in a pilot-scale LED-illuminated photobioreactor, Scheme S2: 
Isolation procedure for new amphidinol analogues, Table S1: 1H and 13C NMR data (600 MHz, 
CD3OD) for amphidinols 24, 25 and 27, Table S2: 1H and 13C NMR data comparison for carbons C-
30  C-51 in CD3OD-C5D5N 2:1 for amphidinol 24 versus related synthetic fragments 4a and 4b 
reported by Wakamiya et al. [22], Figures S1–S15: 1D and 2D NMR spectra for amphidinol 24, Figure 
S16: HRESIMS spectrum for amphidinol 24, Figure S17: Main MS/MS fragments observed for am-
phidinol 24, Figures S18–S22: 1D and 2D NMR spectra for amphidinol 25, Figure S23: HRESIMS 
spectrum for amphidinol 25, Figure S24: Main MS/MS fragments observed for amphidinol 25, Fig-
ures S25–S31: 1D and 2D NMR spectra for amphidinol 26, Figure S32: HRESIMS spectrum for am-
phidinol 26, Figure S33: Amphidinol 26 conversion from aldehyde to carboxylic acid at C-54 ob-
served by ESI-HRMS, Figure S34: Amphidinol 26 single mass composition analysis for aldehyde 
and carboxylic states, Figure S35: Main MS/MS fragments observed for amphidinol 26, Figures S36 
and S38: 1H NMR and HSQCed spectra of known luteophanol D and amphidinol 20B, Figures S37 
and S39: HRESIMS spectra of known luteophanol D and amphidinol 20B.  
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